Chemoinformaics analysis of 1,3,5-Trihydroxy-6,7-dimethoxy-2-methylanthraquinone
| Molecular Weight | 330.292 | nRot | 2 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 18 |
| Exact Molecular Weight | 330.074 | nRing | 3 |
| Solubility: LogS | -3.978 | nHRing | 0 |
| Solubility: LogP | 3.358 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 43.3391 |
| nHD | 3 | BPOL | 19.2529 |
| QED | 0.657 |
| Synth | 2.57 |
| Natural Product Likeliness | 1.42 |
| NR-PPAR-gamma | 0.887 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.784 |
| Pgp-sub | 0.006 |
| HIA | 0.378 |
| CACO-2 | -5.244 |
| MDCK | 0.0000113 |
| BBB | 0.008 |
| PPB | 0.986673 |
| VDSS | 0.4 |
| FU | 0.0394646 |
| CYP1A2-inh | 0.585 |
| CYP1A2-sub | 0.955 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.087 |
| CYP2c9-inh | 0.558 |
| CYP2c9-sub | 0.248 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.179 |
| CYP3a4-inh | 0.302 |
| CYP3a4-sub | 0.204 |
| CL | 10.276 |
| T12 | 0.435 |
| hERG | 0.026 |
| Ames | 0.753 |
| ROA | 0.089 |
| SkinSen | 0.496 |
| Carcinogencity | 0.166 |
| EI | 0.914 |
| Respiratory | 0.095 |
| NR-Aromatase | 0.725 |
| Antiviral | Yes |
| Prediction | 0.830884 |